Cargando…

MicroRNA-670 aggravates cerebral ischemia/reperfusion injury via the Yap pathway

Apoptosis is an important programmed cell death process involved in ischemia/reperfusion injury. MicroRNAs are considered to play an important role in the molecular mechanism underlying the regulation of cerebral ischemia and reperfusion injury. However, whether miR-670 can regulate cell growth and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shi-Jia, Yu, Ming-Jun, Bu, Zhong-Qi, He, Ping-Ping, Feng, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224117/
https://www.ncbi.nlm.nih.gov/pubmed/33269746
http://dx.doi.org/10.4103/1673-5374.300455
_version_ 1783711828932558848
author Yu, Shi-Jia
Yu, Ming-Jun
Bu, Zhong-Qi
He, Ping-Ping
Feng, Juan
author_facet Yu, Shi-Jia
Yu, Ming-Jun
Bu, Zhong-Qi
He, Ping-Ping
Feng, Juan
author_sort Yu, Shi-Jia
collection PubMed
description Apoptosis is an important programmed cell death process involved in ischemia/reperfusion injury. MicroRNAs are considered to play an important role in the molecular mechanism underlying the regulation of cerebral ischemia and reperfusion injury. However, whether miR-670 can regulate cell growth and death in cerebral ischemia/reperfusion and the underlying mechanism are poorly understood. In this study, we established mouse models of transient middle artery occlusion and Neuro 2a cell models of oxygen-glucose deprivation and reoxygenation to investigate the potential molecular mechanism by which miR-670 exhibits its effects during cerebral ischemia/reperfusion injury both in vitro and in vivo. Our results showed that after ischemia/reperfusion injury, miR-670 expression was obviously increased. After miR-670 expression was inhibited with an miR-670 antagomir, cerebral ischemia/reperfusion injury-induced neuronal death was obviously reduced. When miR-670 overexpression was induced by an miR-670 agomir, neuronal apoptosis was increased. In addition, we also found that miR-670 could promote Yap degradation via phosphorylation and worsen neuronal apoptosis and neurological deficits. Inhibition of miR-670 reduced neurological impairments after cerebral ischemia/reperfusion injury. These results suggest that microRNA-670 aggravates cerebral ischemia/reperfusion injury through the Yap pathway, which may be a potential target for treatment of cerebral ischemia/reperfusion injury. The present study was approved by the Institutional Animal Care and Use Committee of China Medical University on February 27, 2017 (IRB No. 2017PS035K).
format Online
Article
Text
id pubmed-8224117
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-82241172021-07-02 MicroRNA-670 aggravates cerebral ischemia/reperfusion injury via the Yap pathway Yu, Shi-Jia Yu, Ming-Jun Bu, Zhong-Qi He, Ping-Ping Feng, Juan Neural Regen Res Research Article Apoptosis is an important programmed cell death process involved in ischemia/reperfusion injury. MicroRNAs are considered to play an important role in the molecular mechanism underlying the regulation of cerebral ischemia and reperfusion injury. However, whether miR-670 can regulate cell growth and death in cerebral ischemia/reperfusion and the underlying mechanism are poorly understood. In this study, we established mouse models of transient middle artery occlusion and Neuro 2a cell models of oxygen-glucose deprivation and reoxygenation to investigate the potential molecular mechanism by which miR-670 exhibits its effects during cerebral ischemia/reperfusion injury both in vitro and in vivo. Our results showed that after ischemia/reperfusion injury, miR-670 expression was obviously increased. After miR-670 expression was inhibited with an miR-670 antagomir, cerebral ischemia/reperfusion injury-induced neuronal death was obviously reduced. When miR-670 overexpression was induced by an miR-670 agomir, neuronal apoptosis was increased. In addition, we also found that miR-670 could promote Yap degradation via phosphorylation and worsen neuronal apoptosis and neurological deficits. Inhibition of miR-670 reduced neurological impairments after cerebral ischemia/reperfusion injury. These results suggest that microRNA-670 aggravates cerebral ischemia/reperfusion injury through the Yap pathway, which may be a potential target for treatment of cerebral ischemia/reperfusion injury. The present study was approved by the Institutional Animal Care and Use Committee of China Medical University on February 27, 2017 (IRB No. 2017PS035K). Wolters Kluwer - Medknow 2020-11-27 /pmc/articles/PMC8224117/ /pubmed/33269746 http://dx.doi.org/10.4103/1673-5374.300455 Text en Copyright: © 2021 Neural Regeneration Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Research Article
Yu, Shi-Jia
Yu, Ming-Jun
Bu, Zhong-Qi
He, Ping-Ping
Feng, Juan
MicroRNA-670 aggravates cerebral ischemia/reperfusion injury via the Yap pathway
title MicroRNA-670 aggravates cerebral ischemia/reperfusion injury via the Yap pathway
title_full MicroRNA-670 aggravates cerebral ischemia/reperfusion injury via the Yap pathway
title_fullStr MicroRNA-670 aggravates cerebral ischemia/reperfusion injury via the Yap pathway
title_full_unstemmed MicroRNA-670 aggravates cerebral ischemia/reperfusion injury via the Yap pathway
title_short MicroRNA-670 aggravates cerebral ischemia/reperfusion injury via the Yap pathway
title_sort microrna-670 aggravates cerebral ischemia/reperfusion injury via the yap pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224117/
https://www.ncbi.nlm.nih.gov/pubmed/33269746
http://dx.doi.org/10.4103/1673-5374.300455
work_keys_str_mv AT yushijia microrna670aggravatescerebralischemiareperfusioninjuryviatheyappathway
AT yumingjun microrna670aggravatescerebralischemiareperfusioninjuryviatheyappathway
AT buzhongqi microrna670aggravatescerebralischemiareperfusioninjuryviatheyappathway
AT hepingping microrna670aggravatescerebralischemiareperfusioninjuryviatheyappathway
AT fengjuan microrna670aggravatescerebralischemiareperfusioninjuryviatheyappathway